153 related articles for article (PubMed ID: 22495669)
1. A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice.
de Ridder GG; Ray R; Pizzo SV
Melanoma Res; 2012 Jun; 22(3):225-35. PubMed ID: 22495669
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NF-kappaB1 and NF-kappaB2 activation in prostate cancer cells treated with antibody against the carboxyl terminal domain of GRP78: effect of p53 upregulation.
Misra UK; Kaczowka S; Pizzo SV
Biochem Biophys Res Commun; 2010 Feb; 392(4):538-42. PubMed ID: 20097177
[TBL] [Abstract][Full Text] [Related]
3. N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.
Ishii-Osai Y; Yamashita T; Tamura Y; Sato N; Ito A; Honda H; Wakamatsu K; Ito S; Nakayama E; Okura M; Jimbow K
J Dermatol Sci; 2012 Jul; 67(1):51-60. PubMed ID: 22622238
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum.
Gonzalez-Gronow M; Cuchacovich M; Llanos C; Urzua C; Gawdi G; Pizzo SV
Cancer Res; 2006 Dec; 66(23):11424-31. PubMed ID: 17145889
[TBL] [Abstract][Full Text] [Related]
5. The monomeric receptor binding domain of tetrameric α2-macroglobulin binds to cell surface GRP78 triggering equivalent activation of signaling cascades.
Misra UK; Payne S; Pizzo SV
Biochemistry; 2013 Jun; 52(23):4014-25. PubMed ID: 23721263
[TBL] [Abstract][Full Text] [Related]
6. Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells.
Misra UK; Pizzo SV
Cancer Biol Ther; 2010 Jan; 9(2):142-52. PubMed ID: 20368692
[TBL] [Abstract][Full Text] [Related]
7. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
8. Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis.
Misra UK; Mowery Y; Kaczowka S; Pizzo SV
Mol Cancer Ther; 2009 May; 8(5):1350-62. PubMed ID: 19417154
[TBL] [Abstract][Full Text] [Related]
9. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
10. Novel immunohistochemical monoclonal antibody against human glucose-regulated protein 78.
Yang L; Su M; Ma Y; Hao X
Hybridoma (Larchmt); 2011 Dec; 30(6):559-62. PubMed ID: 22149283
[TBL] [Abstract][Full Text] [Related]
11. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
[TBL] [Abstract][Full Text] [Related]
12. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
13. Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis.
Lin YG; Shen J; Yoo E; Liu R; Yen HY; Mehta A; Rajaei A; Yang W; Mhawech-Fauceglia P; DeMayo FJ; Lydon J; Gill P; Lee AS
Oncogene; 2015 Oct; 34(43):5418-26. PubMed ID: 25684138
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the unfolded protein response in prostate cancer cells by antibody-directed against the carboxyl-terminal domain of GRP78.
Misra UK; Pizzo SV
Apoptosis; 2010 Feb; 15(2):173-82. PubMed ID: 20091233
[TBL] [Abstract][Full Text] [Related]
15. Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses.
Misra UK; Pizzo SV
J Biol Chem; 2015 Apr; 290(15):9571-87. PubMed ID: 25720493
[TBL] [Abstract][Full Text] [Related]
16. Methylselenol generated from selenomethionine by methioninase downregulates integrin expression and induces caspase-mediated apoptosis of B16F10 melanoma cells.
Kim A; Oh JH; Park JM; Chung AS
J Cell Physiol; 2007 Aug; 212(2):386-400. PubMed ID: 17348006
[TBL] [Abstract][Full Text] [Related]
17. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
18. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
19. An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling.
Sala G; Traini S; D'Egidio M; Vianale G; Rossi C; Piccolo E; Lattanzio R; Piantelli M; Tinari N; Natali PG; Muraro R; Iacobelli S;
Oncogene; 2012 Mar; 31(10):1275-86. PubMed ID: 21822299
[TBL] [Abstract][Full Text] [Related]
20. A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice.
Iakoubov LZ; Torchilin VP
Oncol Res; 1997; 9(8):439-46. PubMed ID: 9436197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
